Delivery Order SPE2DB24D2011-SPE2DB25FBQHQ

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $60,045.24 and is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $2,793.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567110760 - DROXIDOPA 200 MG CAPSULE 90S, with an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a ceiling value of $37,579.10 and a performance period through March 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,586.62 firm fixed-price contract is for the delivery of 4,564,640,389 units of the drug Droxidopa 100 mg capsules. The contract has a completion date of May 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $6,776.80, is a delivery order placed by the Defense Logistics Agency (DLA) to supply 4,564,666,798 units of the prescription medication droxidopa 200 mg capsule in quantities of 90s. The award has no set-aside designation and is a firm fixed-price contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This is a $31,094.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was not set aside for any specific business category. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,470.35, is a delivery order for the supply of 4566478383 ! DEXTROAMP-AMPHET ER 25 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.11 firm fixed-price delivery order contract has an ultimate completion date of March 4, 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQHQ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,555.09, is for the delivery of 4567678075 ! DROXIDOPA 100 MG CAPSULE 90S.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The contract has a firm fixed price pricing type and an ultimate completion date of March 25, 2025.

Generated 6/29/25, 1:14 AM